EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

Andrew Rodriguez, Carlos Kamiya-Matsuoka, Nazanin K Majd

Current Oncology · 2023

DOI: 10.3390/curroncol30060401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Andrew Rodriguez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Neoplasms, Germ Cell and Embryonal, Rhabdoid Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Establishing novel therapies for rare central nervous system (CNS) tumors is arduous due to challenges in conducting clinical trials in rare tumors. Immunotherapy treatment has been a rapidly developing field and has demonstrated improvements in outcomes for multiple types of solid malignancies. In rare CNS tumors, the role of immunotherapy is being explored. In this article, we review the preclinical and clinical data of various immunotherapy modalities in select rare CNS tumors, including atypical meningioma, aggressive pituitary adenoma, pituitary carcinoma, ependymoma, embryonal tumor, atypical teratoid/rhabdoid tumor, and meningeal solitary fibrous tumor. Among these tumor types, some studies have shown promise; however, ongoing clinical trials will be critical for defining and optimizing the role of immunotherapy for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsNeoplasms, Germ Cell and EmbryonalRhabdoid TumorHumansImmunotherapy

Stichwörter der Autor:innen

central nervous system tumorsimmunotherapyraretreatment

Autor:innen und Institutionen

  • Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.

Zitieren

APA

Rodriguez, A., Kamiya-Matsuoka, C., & Majd, N. K. (2023). The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors. Current Oncology. https://doi.org/10.3390/curroncol30060401

Vancouver

Rodriguez A, Kamiya-Matsuoka C, Majd NK. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors. Current Oncology. 2023. doi:10.3390/curroncol30060401

BibTeX
@article{Rodriguez2023,
  author = {Rodriguez, Andrew and Kamiya-Matsuoka, Carlos and Majd, Nazanin K},
  title = {The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30060401}
}
Kostenlos starten →